The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A Powerful Nonviral Vector for In Vivo Gene Transfer into the Adult Mammalian Brain: Polyethylenimine
Abstract
Nonviral gene transfer into the central nervous system (CNS) offers the prospect of providing safe therapies for neurological disorders and manipulating gene expression for studying neuronal function. However, results reported so far have been disappointing. We show that the cationic polymer polyethylenimine (PEI) provides unprecedentedly high levels of transgene expression in the mature mouse brain. Three different preparations of PEI (25-, 50-, and 800-kD) were compared for their transfection efficiencies in the brains of adult mice. The highest levels of transfection were obtained with the 25-kD polymer. With this preparation, DNA/PEI complexes bearing mean ionic charge ratios closest to neutrality gave the best results. Under such conditions, and using a cytomegalovirus (CMV)–luciferase construction, we obtained up to 0.4 106 RLU/μg DNA (equivalent to 0.4 ng of luciferase), which is close to the values obtained using PEI to transfect neuronal cultures and the more easily transfected newborn mouse brain (106 RLU/μg DNA). Widespread expression (over 6 mm3) of marker (luciferase) or functional genes (bcl2) was obtained in neurons and glia after injection into the cerebral cortex, hippocampus, and hypothalamus. Transgene expression was found more than 3 months post-injection in cortical neurons. No morbidity was observed with any of the preparations used. Thus, PEI, a low-toxicity vector, appears to have potential for fundamental research and genetic therapy of the brain. Nonviral gene transfer into the adult mammalian brain offers the prospects of safe therapies and new experimental possibilities. However, results reported so far have been disappointing. We show that the cationic polymer polyethylenimine (PEI) provides high levels of transgene expression in the mature mouse brain. We used polymer preparations of low mean molecular weight and a polymer/DNA charge ratio near neutrality. Widespread expression (over 6 mm3) of marker (luciferase) or functional genes (bcl2) was obtained in neurons and glia after injection into the cerebral cortex, hippocampus, and hypothalamus. Transgene expression was found more than 3 months post-injection in cortical neurons. Thus, PEI, a low-toxicity vector, appears to have potential for fundamental research and genetic therapy of the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Self-citationLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · cited 2×
“…CNS. ing The number of cells ti^sfected (several thousand) is witiiin the same range as re ported for adenoviral gene ttansfer (Akli et al, 1993) and or ders of magnitude greater dian levels (a few cells) obtained with die HIV-derived vector (Naldini et al, 1996) and all nonviral reports so far.”
Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., & Blaese, R. M. (1992) · Science · doi:10.1126/science.1317968 · Cited by 1,509
Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O'Malley, K. L., & During, M. J. (1994) · Nature Genetics · doi:10.1038/ng1094-148 · Cited by 1,031
An Adenovirus Vector for Gene Transfer into Neurons and Glia in the Brain
La Salle, G. L. G., Robert, J. J., Berrard, S., Ridoux, V., Stratford-Perricaudet, L. D., Perricaudet, M., & Mallet, J. (1993) · Science · doi:10.1126/science.8382374 · Cited by 738
Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
Behr, J. P., Demeneix, B., Loeffler, J. P., & Perez-Mutul, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6982 · Cited by 719
Self-citationPrevention of Programmed Cell Death of Sympathetic Neurons by the bcl-2 Proto-Oncogene
Garcia, I., Martinou, I., Tsujimoto, Y., & Martinou, J.-C. (1992) · Science · doi:10.1126/science.1411528 · Cited by 717
A model system for in vivo gene transfer into the central nervous system using an adenoviral vector
Davidson, B. L., Allen, E. D., Kozarsky, K. F., Wilson, J. M., & Roessler, B. J. (1993) · Nature Genetics · doi:10.1038/ng0393-219 · Cited by 575
Cited by
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
“Additionally, PEI has been successful for in vivo gene delivery to a variety of tissues, including the central nervous syste”
BackgroundReddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Pathological and protective roles of glia in chronic pain
Milligan, E. D., & Watkins, L. R. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2533 · Cited by 1,399
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Fischer, D., Bieber, T., Li, Y., Elsässer, H.-P., & Kissel, T. (1999) · Pharmaceutical Research · doi:10.1023/a:1014861900478 · Cited by 1,217
Poly(ethylenimine) and its role in gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00090-5 · Cited by 1,199
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
Neu, M., Fischer, D., & Kissel, T. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.773 · Cited by 866
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19990605)45:3<268::aid-jbm15>3.0.co;2-q · Cited by 825
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5177 · Cited by 822
Kunath, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00076-2 · Cited by 809
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
Magnetic nanoparticles for gene and drug delivery
Dobson (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1608 · Cited by 755
Pollard, H., Remy, J.-S., Loussouarn, G., Demolombe, S., Behr, J.-P., & Escande, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7507 · Cited by 711
Self-citationDifferent behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo
Wightman, L., Kircheis, R., R�ssler, V., Carotta, S., Ruzicka, R., Kursa, M., & Wagner, E. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.187 · Cited by 697
Design and gene delivery activity of modified polyethylenimines
Kircheis, R., Wightman, L., & Wagner, E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00202-2 · Cited by 651
Nonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer
Nishikawa, M., & Huang, L. (2001) · Human Gene Therapy · doi:10.1089/104303401750195836 · Cited by 574
Ogris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R., & Wagner, E. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300745 · Cited by 571
Köping-Höggård, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Vårum, K., & Artursson, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301492 · Cited by 532
Characterization of commercially available and synthesized polyethylenimines for gene delivery
von Harpe, A., Petersen, H., Li, Y., & Kissel, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00317-5 · Cited by 519
Gary, D. J., Puri, N., & Won, Y.-Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.021 · Cited by 514
Poly(2-oxazolines) in biological and biomedical application contexts
Adams, N., & Schubert, U. S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.018 · Cited by 492
Efficient Gene Transfer Using Reversibly Cross-Linked Low Molecular Weight Polyethylenimine
Gosselin, M. A., Guo, W., & Lee, R. J. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0100455 · Cited by 454
The synthesis, properties and potential applications of cyclic polymers
Haque, F. M., & Grayson, S. M. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0440-5 · Cited by 417
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
Collier, L. S., Carlson, C. M., Ravimohan, S., Dupuy, A. J., & Largaespada, D. A. (2005) · Nature · doi:10.1038/nature03681 · Cited by 406
Köping-Höggård, M., Vårum, K., Issa, M., Danielsen, S., Christensen, B., Stokke, B., & Artursson, P. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302312 · Cited by 385
Development of Biomaterials for Gene Therapy
Han, S.-O., Mahato, R. I., Sung, Y. K., & Kim, S. W. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0142 · Cited by 384
Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine
Choi, J. S., Nam, K., Park, J.-Y., Kim, J.-B., Lee, J.-K., & Park, J.-S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.027 · Cited by 382
Akinc, A., Lynn, D. M., Anderson, D. G., & Langer, R. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034429c · Cited by 376
Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes
Chollet, P., Favrot, M. C., Hurbin, A., & Coll, J. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.237 · Cited by 373
Polycation-based DNA complexes for tumor-targeted gene deliveryin vivo
Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K.-H., Zauner, W., & Wagner, E. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199903/04)1:2<111::aid-jgm22>3.0.co;2-y · Cited by 356
Intracellular route and transcriptional competence of polyethylenimine–DNA complexes
Bieber, T., Meissner, W., Kostin, S., Niemann, A., & Elsasser, H.-P. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00129-3 · Cited by 354
Ruponen, M., Ylä-Herttuala, S., & Urtti, A. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00199-0 · Cited by 353
Kircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rössler, V, Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
PDMAEMA based gene delivery materials
Agarwal, S., Zhang, Y., Maji, S., & Greiner, A. (2012) · Materials Today · doi:10.1016/s1369-7021(12)70165-7 · Cited by 342
Polyethylenimine (PEI) in gene therapy: Current status and clinical applications
Casper, J., Schenk, S. H., Parhizkar, E., Detampel, P., Dehshahri, A., & Huwyler, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.001 · Cited by 340
Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
Zou, S.-M., Erbacher, P., Remy, J.-S., & Behr, J.-P. (2000) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(200003/04)2:2<128::aid-jgm95>3.0.co;2-w · Cited by 317
Self-citationErbacher, P., Bettinger, T., Belguise-Valladier, P., Zou, S., Coll, J.-L., Behr, J.-P., & Remy, J.-S. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3<210::aid-jgm30>3.0.co;2-u · Cited by 295
Self-citationSynthesis of Poly(β-amino ester)s Optimized for Highly Effective Gene Delivery
Akinc, A., Anderson, D. G., Lynn, D. M., & Langer, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034067y · Cited by 285
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
Zuckermann, M., Hovestadt, V., Knobbe-Thomsen, C. B., Zapatka, M., Northcott, P. A., Schramm, K., Belic, J., Jones, D. T. W., Tschida, B., Moriarity, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8391 · Cited by 283
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Selby, L. I., Cortez‐Jugo, C. M., Such, G. K., & Johnston, A. P. R. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 283
Werth, S., Urban-Klein, B., Dai, L., Höbel, S., Grzelinski, M., Bakowsky, U., Czubayko, F., & Aigner, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.009 · Cited by 281
Barrans, S. L., Carter, I., Owen, R. G., Davies, F. E., Patmore, R. D., Haynes, A. P., Morgan, G. J., & Jack, A. S. (2002) · Blood · doi:10.1182/blood.v99.4.1136 · Cited by 276
Design of imidazole-containing endosomolytic biopolymers for gene delivery
Pack, D. W., Putnam, D., & Langer, R. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000120)67:2<217::aid-bit11>3.0.co;2-q · Cited by 274
Biophysical Characterization of PEI/DNA Complexes
Choosakoonkriang, S., Lobo, B. A., Koe, G. S., Koe, J. G., & Middaugh, C. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10437 · Cited by 265
Dunckley, M. G., Manoharan, M., Villiet, P., Eperon, I. C., & Dickson, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1083 · Cited by 255
In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides
Kren, B. T., Bandyopadhyay, P., & Steer, C. J. (1998) · Nature Medicine · doi:10.1038/nm0398-285 · Cited by 255
Maia, J., Santos, T., Aday, S., Agasse, F., Cortes, L., Malva, J. O., Bernardino, L., & Ferreira, L. (2011) · ACS Nano · doi:10.1021/nn101724r · Cited by 99
(2003) · PubMed · Cited by 67
Non-viral therapeutic approaches to ocular diseases: An overview and future directions
Zulliger, R., Conley, S. M., & Naash, M. I. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.007 · Cited by 50
Optimising non-viral gene delivery in a tumour spheroid model
Mellor, H. R., Davies, L. A., Caspar, H., Pringle, C. R., Hyde, S. C., Gill, D. R., & Callaghan, R. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.947 · Cited by 49
“The cationic polymer PEI has been shown [19,20] to effectively ‘shield’ the negative surface charge of DNA following the formation of a polyplex and this alteration enables entry to cells.”
BackgroundNovel role and mechanism of protein inhibitor of activated STAT1 in spatial learning
Tai, D. J. C., Hsu, W. L., Liu, Y. C., Ma, Y. L., & Lee, E. H. Y. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.290 · Cited by 47
“The method used for plasmid DNA transfection to brain tissues was adopted from that of a previous report (Abdallah et al, 1996).”
BackgroundMethodLee, C. T., Ma, Y. L., & Lee, E. H. Y. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04284.x · Cited by 32
Tyan, S., Tsai, M., Lin, C., Ma, Y., & Lee, E. H. Y. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05186.x · Cited by 31
Metadata
- Authors
- Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J. P., & Demeneix, B. A.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1996-10-20
- Volume
- 7
- Issue
- 16
- Pages
- 1947-1954
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2048928172
- Cited by
- 541
- References
- 23
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.